Coronavirus Drug Report, Though Inconclusive, Sends Gilead Higher

Canada News News

Coronavirus Drug Report, Though Inconclusive, Sends Gilead Higher
Canada Latest News,Canada Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Some analysts said not much could be learned from partial results at one hospital, and from a set of patients whose progress wasn’t compared with a control group

An encouraging news report about an experimental drug being developed by Gilead Sciences Inc. for Covid-19 led shares of the drugmaker to jump nearly 8% in trading Friday and helped to spur gains in the total market.

A doctor in Chicago told colleagues that Gilead’s drug remdesivir appeared to help many patients enrolled in a clinical trial site at the University of Chicago Medicine hospital, according to a news report in online health publication STAT, which cited a video of the remarks. The doctor said that the hospital...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead drug produced ‘rapid’ recovery in coronavirus patients, report saysGilead drug produced ‘rapid’ recovery in coronavirus patients, report saysGilead stock pops in after-hours trading; its experimental drug remdesivir is considered a front-runner in the race to develop a treatment for COVID-19 infections.
Read more »

Dow futures rally 900 points after report says Gilead drug showing effectiveness against coronavirusDow futures rally 900 points after report says Gilead drug showing effectiveness against coronavirusU.S. stock futures surged on Thursday night after a report said a Gilead Sciences drug was showing effectiveness in treating the coronavirus.
Read more »

Gilead Stock Jumps 8% After Coronavirus Drug Remdesivir Shows ‘Rapid Recoveries’ In Clinical TrialsGilead Stock Jumps 8% After Coronavirus Drug Remdesivir Shows ‘Rapid Recoveries’ In Clinical TrialsShares of biotech company Gilead Sciences, which has been at the forefront of developing a treatment for COVID-19 patients, surged today after a report that a clinical trial for its antiviral drug, Remdesivir, was showing successful results by skleb1234
Read more »

Gilead stock surges more than 10% on report of promising coronavirus treatmentGilead stock surges more than 10% on report of promising coronavirus treatmentGilead Sciences Inc. undefined shares rallied in the extended session Thursday following a report that one of the company's drugs showed promising results in...
Read more »

Dow futures soar 800 points as investors pin hope on Gilead coronavirus treatment and U.S. reopeningDow futures soar 800 points as investors pin hope on Gilead coronavirus treatment and U.S. reopeningStock-index futures Thursday night trade sharply higher, possibly setting the stage for a powerful rally for markets to end the week if the gains hold through tomorrow, amid progress toward a treatment for the deadly COVID-19 pandemic that has claimed more than 2 million lives world-wide.
Read more »

Dow rises over 500 points as investors pin hope on Gilead coronavirus treatment and U.S. reopeningDow rises over 500 points as investors pin hope on Gilead coronavirus treatment and U.S. reopeningStocks opened with strong gains Friday, putting equities on track to end a positive week on a strong note, after a treatment for the deadly COVID-19 pandemic...
Read more »



Render Time: 2025-04-03 16:17:25